These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19000883)

  • 1. [What is the best immunosuppression for the elderly kidney transplantation patient?].
    Ladrière M
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S179-83. PubMed ID: 19000883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression of the elderly kidney transplant recipient.
    Danovitch GM; Gill J; Bunnapradist S
    Transplantation; 2007 Aug; 84(3):285-91. PubMed ID: 17700150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
    Yang H
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toward individualized immunosuppression].
    Grinyó JM
    Nefrologia; 2001; 21(3):232. PubMed ID: 11471302
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppression in corneal transplantation].
    Scheer S; Touzeau O; Borderie V; Laroche L
    J Fr Ophtalmol; 2003 Jun; 26(6):637-47. PubMed ID: 12910207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern approaches to combining sirolimus with calcineurin inhibitors.
    Stevens RB
    Transplant Proc; 2008 Dec; 40(10 Suppl):S21-4. PubMed ID: 19100901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for minimizing immunosuppression in kidney transplantation.
    Kirk AD; Mannon RB; Swanson SJ; Hale DA
    Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mTOR inhibitors reduce the risk of late kidney allograft failure?
    Ponticelli C
    Transpl Int; 2008 Jan; 21(1):2-10. PubMed ID: 17635837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals.
    Filipe R; Mota A; Alves R; Bastos C; Macário F; Figueiredo A; Roseiro A; Parada B; Sá H; Nunes P; Bastos M
    Transplant Proc; 2009 Apr; 41(3):843-5. PubMed ID: 19376367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reviewing the evidence for de novo immunosuppression with sirolimus.
    Flechner SM
    Transplant Proc; 2008 Dec; 40(10 Suppl):S25-8. PubMed ID: 19100902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New immunosuppressive strategies and the risk of infection.
    Mueller NJ
    Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody-mediated acute rejection].
    Lefaucheur C; Nochy D; Glotz D
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.